Clinical Trial Update: Perioperative Chemo and Pembrolizumab in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perioperative chemotherapy with pembrolizumab for gastric cancer and gastroesophageal junction adenocarcinoma has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Gastric Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Gulam Manji | Conditions: Gastric Cancer, Adenocarcinoma of the Gastroesophageal Junction | Phase 2 | Status: COMPLETED | Results posted: 2024-02-15